Siemens Healthcare Diagnostics Inc recalls Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative measurement of N-terminal pro-brain natr…
- Recall date
- November 11, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0610-2016
- FDA classification
- Class II
- Brand / firm
- Siemens Healthcare Diagnostics Inc
- Sold / distributed
- Worldwide Distribution - US (nationwide), Algeria, Armenia, Australia, Austria, Bangladesh, Bosnia Herzegovina, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Libya, Malaysia, Poland, Portugal, Romania, Saudi Arabia, Slovenia, South Africa,…
Why it was recalled
Stratus CS Cartridge Barcode labels may not scan on the Stratus CS systems
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NTproBNP) in heparinized plasma. Catalog Number: CPBNPM SMN: 10445086
Get recall alerts
Free email alert whenever Siemens Healthcare Diagnostics Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Siemens Healthcare Diagnostics Inc